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Abstract Granule cells in a dissociated neuro-glial cell culture
of cerebellum when exposed to ouabain (1033 M) for 25 min
apparently swell, increase their [Ca2+]i with obvious depolariza-
tion of the mitochondrial membrane. In 3 h after ouabain was
omitted from the solution, 62 þ 3% of granule cells had pycnotic
nuclei. The supplement of a solution with competitive specific
antagonist of NMDA receptors, L-2-amino-7-phosphonoheptano-
ate (1034 M, APH) together with ouabain prevented cells from
swelling, mitochondrial deenergization, neuronal death and
increase of [Ca2+]i. These data suggest that cellular Na+/K+-
ATPase inactivation in neuro-glial cell cultures of cerebellum
leads to glutamate (Glu) accumulation, hyperstimulation of
glutamate receptors, higher Ca2+ and Na+ influxes into the cells
through the channels activated by Glu. This process leads to cell
swelling, mitochondrial deenergization and death of granule cells.
Possibly, the decrease of Na+/K+-ATPase activity in brain cells
can lead to the onset of at least some chronic neurological
disorders.
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1. Introduction
The excess of excitotoxic amino acids is though to be one of
the pathogenic factors resulting from the neuronal lesion
under brain damage [1], ischemia and hypoxia [2,3], as well
as under chronic neurological disorders such as Hantington’s
chorea [4,5], epilepsy [6], side amyotrophic sclerosis [7]. The
elevation in the brain of the major excitatory neuromediator,
glutamate (Glu) occurring under neurological disorders may
be due to defects in mitochondrial energy metabolism [8].
Disruption of energy metabolism results in a lowering of the
Na/K-ATPase activity [9], cell depolarization and rising of
intracellular Na. All these processes induce the distortion of
Glu trapping by the cells [10]. The lower Glu trapping results
in its accumulation, hyperactivation of Glu receptors and ¢-
nally, the cell death, the so-called secondary excitotoxicity.
The existing link between the rise of endogenous Glu and
metabolic distortions was supported by data showing that in
neuronal cells the toxic e¡ect of metabolic inhibitors could be
prevented by NMDA receptor blockers [11^13]. However, the
accumulation of endogenous Glu may not occur as a sequence
of impaired cellular energetics, but also as a result of a slower
glutamate uptake through the high-a⁄nity sites. The latter
can be a result of either damage of the transport system or
be mediated by the suppressed activity of Na/K-ATPase
[14]. In this study we were able to demonstrate that in primary
culture of cerebellar granule cells the Na/K-ATPase block-
er, ouabain induced the neuronal death through the secondary
excitotoxicity and hence, the impaired energy metabolism may
be explained by a toxicity manifested by endogenous Glu.
2. Materials and methods
Primary cerebellar cultures were prepared from the cerebella of 7^
8 day old Wistar rats using procedure described earlier [15]. On the
second day of cultivation, the potassium concentration was risen up
to 25 mM. Control cells were exposed for 25 min to a balanced salt
solution (BSS) of the following content (in mM): NaCl 154, KCl 5,
Na2HPO4 0.035, CaCl2 2.3, NaHCO3 3.6, glucose 5.6, HEPES 5, pH
7.6^7.8, 20‡C. Ouabain (Ou, 1 mM) was used to block Na/K-ATP-
ase and APH (D,L-2-amino-7-phosphonoheptanoate, 1034 M) as com-
petitive speci¢c antagonist of NMDA glutamate receptors.
Confocal Laser Scanning Microscope (Bio-Rad MRC 600 CLSM)
was used to evaluate Ca2i changes by monitoring Fluo-3 £uorescence
after intracellular cleavage of Fluo-3 AM (1035 M, Molecular Probes,
with excitation at 488 nm and emission at s 510 nm). Fluorescence
data were obtained by evaluating the £uorescence from selected areas
within a cell, with the following subtraction of the background £uo-
rescence, and division by the £uorescence intensity before application
of drugs (F0) and expressed as F/F0. Since Fluo-3 does not allow
direct quantitative rationing, we also used a semiquantitative method
to estimate [Ca2]I changes as described before [16]. The values of
[Ca2]i were calculated by the equation:
Ca2i  K  F=F0=K=Ca2rest  13F=F0;
where K = 400 nM (dissociation constant of the complex Ca-Fluo-3),
basal calcium [Ca2]rest = 41 nM [17]. Confocal images were stored
every 5 min.
Mitochondrial energization within a cell was monitored by the rise
of rhodamine 123 (R123) £uorescence monitored by Univar £uores-
cence microsope, Reichert, after 10 min of incubation (5U1036 g/ml)
in BSS. For evaluation of viability, treated cells (25 min, 1 mM Ou or
25 min, 154 mM LiCl) were washed twice with BSS and incubated in
this medium for 3 h in CO2 incubator at 35.5‡C for the development
of a delayed neuronal death. After incubation, cells were ¢xed with an
ethanol-formaldehyde-acetic acid (7:2:1) mixture and stained with
vanadium hematoxHline. The percentage of damaged neurons was
determined by counting the intact and pycnotic nuclei of the granule
cells in 81-view ¢elds. Mann-Whitney test was used for statistical
evaluations.
3. Results and discussion
Granule cells in the dissociated neuro-glial cell cultures had
normal morphology past 3 h incubation in BSS (Fig. 1A). Ou
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(1033 M) treatment of granule cells within 25 min caused their
obvious swelling. After 3 h Ou was omitted from the solution,
pycnotic nuclei have been revealed in many neurons (Fig. 1B).
The percentage of the dead cells in treated cultures reached
62 þ 3% of the total amount of granule cells, while in control
only 3% of neurons died (Fig. 1D). Lower Ou concentrations
(1034 M or less) were not toxic for these cells.
Since the transmembrane transport of Glu is sodium de-
pendent, this accompanies Na entry into the cell [18]. The
inactivation of Na/K-ATPase or removal of the external
sodium from cells caused accumulation of extracellular Glu.
Previously, other authors demonstrated that Ou inhibition of
Na/K-ATPase induced the decrease of the glutamate up-
take in cultured cortical astrocytes [19]. Possibly in our experi-
ments, the hyperstimulation of Glu receptors by endogenous
Glu leads to the death of the neurons. For testing the possi-
bility that neuronal NMDA channels are activated by the
Glu, released from internal sources of the cells, the granule
cells were incubated in Ou-containing solution in the presence
of 1034 M APH, a competitive speci¢c antagonist of NMDA
glutamate receptors. This blocker prevented both the ouabain-
induced swelling and death of granule cells (Fig. 1C, D). In an
attempt to support the idea that the inhibition of Glu trans-
port into the cells may result in an accumulation of Glu to a
toxical level, we substituted the NaCl in BSS for LiCl (LiBSS),
as it is known that Li competes with Na for binding with
Na/K-ATPase and signi¢cantly lowers its functional activ-
ity [20]. Also this substitution is known to diminish Glu up-
take [21]. The incubation of the cell cultures in LiBSS induced
the death of 36% granule cells. This toxic e¡ect has been
completely prevented by APH (Fig. 2). In these experiments,
the density of granule cells in experimental cell cultures ex-
ceeded 5U103 cells/mm2. The toxicity of Ou and Li was not
observed in the cell cultures with a lower cell density.
A number of studies demonstrated that hyperstimulation of
Fig. 1. The evidence that the inhibition of Na/K-ATPase in the glial-neuronal monolayer culture induces the damage of cerebellar granule
cells with APH preventing this e¡ect. Bar = 1.4U1035 m. Vanadium hematoxylin staining. A: Control culture exposed to BSS for 205 min. B:
Cultures exposed to BSS for 180 min followed by 25 min in OBSS. Arrowheads indicate the pycnotic nuclei of dead granule cells. C: Cultures
exposed to BSS for 180 min followed by 25 min exposure to OBSS with 1034 M APH. D: Viability of granule cells after the cease of the
Na/K-ATPase. Lane 1, control culture exposed to BSS for 205 min; lane 2, 180 min in BSS after 25 min exposure to OBSS; lane 3, 180 min
in BSS after 25 min exposure to OBSS with 1034 M APH. Lanes 2 and 3, *P6 0.001, n = 81^99; U-test.
Fig. 2. Viability of granule cells after incubation in a Li-containing
solution with low Na. Lane A, control culture exposed to BSS for
205 min; lane B, 180 min in BSS after 25 min exposure to LiBSS;
lane C, 180 min in BSS after 25 min exposure to LiBSS with 0.1
mM APH. Lanes B and C, *P6 0.01, n = 81^99; U-test.
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glutamate receptors results in Ca2 overloading of the neuro-
nal cytosol [22,23].
The measurement of Fluo-3 £uorescence in the cytosol of
granule cells shows the increase of Fluo-3 £uorescence in the
neurons of Ou treated neuro-glial cell cultures (Fig. 3B, B1).
By using the semiquantitative methods of evaluation of
[Ca2]i changes [16] we estimated that after the ouabain ex-
posure of cell cultures for 20 min, [Ca2]i of granule cells
increased from a basal level (41 nM) to 425 nM and 30 min
exposure resulted in the maximal rise of the [Ca2]i to 1084
nM (Fig. 4). The supplement of the ouabain-containing solu-
tion with the competitive speci¢c antagonist of NMDA re-
ceptor, APH (1034 M), signi¢cantly abolished the ouabain-
induced [Ca2]i increase (Figs. 3C, C1, 4). In this case, the
maximal increase of the intracellular calcium in granule cells
from Ou and APH treated cell cultures was 147 nM.
The [Ca2]i was not changing in the control cells for all the
Fig. 3. The measurement of Fluo-3 £uorescence in the cytosol of
granule cells shows the increase of Fluo-3 £uorescence in the neu-
rons of Ou treated neuro-glial cell cultures. A: Control, 1 min BSS;
A1: control, 30 min BSS; B: 1 min BSS+1 mM ouabain; B1:
30 min BSS+1 mM ouabain; C: 1 min BSS+1033 M ouabain+1034
M APH; C1: 30 min BSS+1033 M ouabain+1034 M APH.
Fig. 4. Increase of intracellular calcium in cerebellar granule cells by
ouabain is inhibited by an NMDA receptor antagonist, APH.
Fig. 5. Photomicrograph of living granule cells in cerebellar dissoci-
ated culture stained with mitochondrial membrane potential £uores-
cent probe, rhodamine 123. Bar = 1.4U1035 m. A: Brightly £uores-
cent mitochondria in granule cells (arrows) exposed to balanced salt
solution for 25 min and then to rhodamine 123. B: Granule cells
after 25 min exposure to balanced salt solution with 1 mM ouabain
followed by rhodamine 123 staining. Faintly £uorescent mitochon-
dria in granule cells (arrows) demonstrate the loss of the mitochon-
drial membrane potential. C: Granule cells after 25 min exposure to
balanced salt solution with 1033 M ouabain with 1034 M APH fol-
lowed by rhodamine 123 staining. Note brightly £uorescent mito-
chondria inside granule cells (arrows) demonstrating high membrane
potential.
FEBS 22371 23-7-99
E.V. Stelmashook et al./FEBS Letters 456 (1999) 41^44 43
incubation times in BSS (Figs. 3A, A1, 4). Due to the above
shown sensitivity of the intracellular entry of Ca2 to speci¢c
blocker of NMDA channel, APH, we conclude that in granule
cells, when incubated in the Ou-containing medium, calcium
ions enter the neurons preferentially through NMDA chan-
nels activated by Glu.
Many drugs causing cellular damage are known to use mi-
tochondria as a primary target [24,25]. In order to evaluate
the in£uence of Ou on the mitochondrial energization in a
cell, the mitochondrial membrane potential was monitored
by rhodamine 123 (R123) £uorescence due to accumulation
in mitochondria. After 25 min of incubation granule cells in
BSS, the neuronal mitochondria showed an active accumula-
tion of R123 which followed from intense green £uorescence
after the excitation of a cell with a blue light (Fig. 5A). At the
same time, very dim £uorescence was observed within granule
cells treated with 1 mM Ou for the same period of time after
loading with R123 (Fig. 5B). The competitive antagonist of
NMDA glutamate receptors, APH prevented mitochondrial
deenergization (Fig. 5C). Previously we, as well as other au-
thors, have demonstrated that excessive Ca2 entrance into
neurons induced by glutamate resulted in a fast collapse of
the mitochondrial membrane potential within these cells [26^
30].
The protection by APH from Ou toxicity, as well as the
resemblance of Ou-induced cells death in neuro-glial cell cul-
tures of cerebellum with that developed after Glu treatment in
some features like cells swelling, increase of [Ca2]i, mitochon-
drial deenergization and the appearing of pycnotic nuclei, all
allow to suggest that the inactivation of Na/K-ATPase in
neuro-glial cell cultures may lead to cell absorbing the re-
leased Glu which is high enough for being toxic for neurons.
Possibly, the decrease of Na/K-ATPase activity in brain
cells can lead to the onset of at least some chronic neuro-
logical disorders. This idea is supported by the ¢ndings that
in epileptic cortex the glial Na/K-ATPase is altered [31,32]
and this is accompanied by the increase of Glu level in the
epileptic brain. Possibly, in this case the release of endogenous
Glu has a strong impact on the energetic metabolism and
¢nally results in neuronal death.
Relatively high e¡ective concentrations of ouabain used
may be due to participation of Na/K-ATPase isozyme
(K1) for its known low a⁄nity to ouabain [33,34]. This type
of Na/K-ATPase is known to be present in both neuronal
and glial cells. If so, both types of cell may participate in Glu
release as well as in Glu capture.
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